GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » Treasury Stock

HCmed Innovations Co (ROCO:6934) Treasury Stock : NT$0.0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. HCmed Innovations Co's treasury stock for the quarter that ended in Dec. 2024 was NT$0.0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


HCmed Innovations Co Treasury Stock Historical Data

The historical data trend for HCmed Innovations Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HCmed Innovations Co Treasury Stock Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Treasury Stock
- - - -

HCmed Innovations Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Treasury Stock Get a 7-Day Free Trial - - - - -

HCmed Innovations Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.


HCmed Innovations Co Business Description

Traded in Other Exchanges
N/A
Address
Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product include Pulmogine and AdheResp.

HCmed Innovations Co Headlines

No Headlines